Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Clinical trial NCT06458712 · RECRUITING

Trial details

NCT number: NCT06458712
Sponsor: Duke Street Bio Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)

Start date: 2024-11-21
Primary completion: 2028-08-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.